HZD.L Share News (HZD)
HZD Share
HZD Share
HZD Share
HZD Share
HZD
HZD Share
HZD Broker
HZD Directors
HZD Financial
HZD
HZD Short
HZDWed, 29th Jul 2020 15:45
Horizon Discovery Group PLC - Gene editing company based in Cambridge - Signs set of commercial license agreements for CHOSOURCE gene editing platform with biopharmaceutical firm TrueBinding Inc. TrueBinding to use platform to help further its medication in immuno-oncology and other fields with "unmet medical need".
Current stock price: 103.50 pence
Year-to-date change: down 31%
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
Horizon Discovery Shares Cancelled Following Acquisition By PerkinElmer
Read moreUK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain
Read moreUK TRADING UPDATE SUMMARY: Ruffer Says Portfolio Makes Progress
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read moreHorizon Discovery Licenses CHOSource To China's Sanyou
Read moreHorizon Discovery Surges As Agrees To Bumper GBP296 Million Takeover
Read more
(Sharecast News) - Horizon Discovery shares surged on Monday after it agreed to be bought by PerkinElmer in a deal that values the cell engineering company at around £284m.
Read moreUK WINNERS & LOSERS SUMMARY: Ocado Shares Up; Big AIM Risers Amid M&A
Read moreHorizon Discovery Sees Recovery After Covid-19 Hits Academic Research
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read moreIN BRIEF: Horizon Discovery Expects Revenue Decline In First Half
Read more(Sharecast News) - Horizon Discovery Group updated the market on its plans for a public offering in the United States on Wednesday, confirming it was restarting its efforts to go ahead with one.
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read moreIN BRIEF: Horizon Discovery Introduces Gene-Editing Cell Lines
Read more